Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB
August 14 2024 - 4:45PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM
12b-25
SEC
File Number 0-15415
CUSIP
Number 816291108
NOTICE
OF LATE FILING
(Check
One):
☐
Form 10-K ☐ Form 11-K ☐ Form 20-F ☒ Form 10-Q ☐ Form N-SAR
For
Period Ended: June 30, 2024
If
the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates: N/A
Part
I—Registrant Information
Full
Name of Registrant: Selectis Health, Inc.
Former
Name if Applicable:
Address
of Principal Executive Office (Street and Number):
8480
E. Orchard Road, Ste. 4900,
Greenwood
Village, CO 80111
Emerging growth company |
☒ |
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Part
II—Rules 12b-25(b) and (c)
If
the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12(b)-25(b),
the following should be completed. (Check box if appropriate)
(a) |
☐ |
The
reasons described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense; |
(b) |
☒ |
The
subject annual report or semi-annual report/portion thereof will be filed on or before the fifteenth calendar day following the prescribed
due date; or the subject quarterly report/portion thereof will be filed on or before the fifth calendar day following the prescribed
due date; and |
(c) |
☐ |
The
accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable. |
Part
III—Narrative
State
below in reasonable detail the reasons why form 10-K, 11-K, 20-F, 10-Q or N-SAR or portion thereof could not be filed within the prescribed
time period.
The
Registrant is unable to file its Quarterly Report on Form 10-Q within the prescribed time period because the Company has not completed
the preparation of its unaudited financial statements for the fiscal quarter.
Part
IV—Other Information
(1) |
Name
and telephone number of person to contact in regard to this notification |
Clifford
L. Neuman, P.C.
6800
N. 79th Street, Ste. 200
Niwot,
Colorado 80503
(303)
449-2100
(2) |
Have
all other period reports required under section 13 or 15(d) of the Securities Exchange Act of 1934 or section 30 of the Investment
Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s)
been filed? If the answer is no, identify report(s). |
|
|
|
The
Registrant’s 10-K for FYE 12/31/22 has yet to be filed. |
|
☒
Yes ☐ No |
|
|
(3) |
Is
it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be
reflected by the earnings statements to be included in the subject report or portion thereof? |
|
☐
Yes ☒ No |
If
so; attach an explanation of the anticipated change, both narratively and quantitively, and, if appropriate, state the reasons why a
reasonable estimate of the results cannot be made.
SELECTIS
HEALTH, INC.
(Name
of Registrant as specified in charter)
has
caused this notification to be signed on its behalf by the undersigned thereunto duly authorized.
Date:
|
August
14, 2024 |
|
By: |
/s/
Adam Desmond |
|
|
|
|
Adam
Desmond, CEO |
Selectis Health (PK) (USOTC:GBCS)
Historical Stock Chart
From Jul 2024 to Aug 2024
Selectis Health (PK) (USOTC:GBCS)
Historical Stock Chart
From Aug 2023 to Aug 2024